Hattersley G, Chambers T J
Department of Histopathology, St George's Hospital Medical School, London, England.
J Cell Physiol. 1989 Sep;140(3):478-82. doi: 10.1002/jcp.1041400311.
Osteoclasts are the cells that resorb bone. It is generally presumed, on the basis of indirect experiments, that they are derived from the hemopoietic stem cell. However, this origin has never been established. We have developed an assay for osteoclastic differentiation in which bone marrow cells are incubated in liquid culture on slices of cortical bone. The bone slices are inspected in the scanning electron microscope after incubation for the presence of excavations, which are characteristic of osteoclastic activity. We have now incubated bone marrow cells at low density, or a factor-dependent mouse hemopoietic cell line (FDCP-mix A4) with 1,25 dihydroxyvitamin D3 (a hormone which we have previously found induces osteoclastic differentiation) with and without murine bone marrow stromal cells, or with and without 3T3 cells, on bone slices. Neither the bone marrow cells nor the bone marrow stromal cells alone developed osteoclastic function even in the presence of 1,25 dihydroxyvitamin D3. However, extensive excavation of the bone surface was observed, only in the presence of 1,25 dihydroxyvitamin D3, on bone slices on which bone marrow stromal cells were cocultured with low-density bone marrow cells or the hemopoietic cell line. Similar results were obtained when the bone marrow stromal cells were killed by glutaraldehyde fixation; 3T3 cells were unable to substitute for stromal cells. These results are strong evidence that osteoclasts derive from the hemopoietic stem cell and suggest that although mature osteoclasts possess neither receptors for nor responsiveness to 1,25 dihydroxyvitamin D3, the hormone induces osteoclastic function through a direct effect on hemopoietic cells rather than through some accessory cell in the bone marrow stroma. The failure of 3T3 cells, which enable differentiation of other hemopoietic progeny from this cell line, to induce osteoclastic differentiation suggests that bone marrow stroma possesses additional characteristics distinct from those that induce differentiation of other hemopoietic cells that are specifically required for osteoclastic differentiation.
破骨细胞是负责吸收骨骼的细胞。基于间接实验,一般推测它们源自造血干细胞。然而,这一来源从未得到证实。我们开发了一种破骨细胞分化检测方法,即将骨髓细胞在皮质骨切片上进行液体培养。培养后,在扫描电子显微镜下检查骨切片,看是否存在破骨细胞活性特征性的凹陷。我们现在将低密度的骨髓细胞,或一种依赖因子的小鼠造血细胞系(FDCP-mix A4)与1,25-二羟维生素D3(我们之前发现这种激素可诱导破骨细胞分化)一起,在有或没有小鼠骨髓基质细胞、有或没有3T3细胞的情况下,接种在骨切片上。单独的骨髓细胞或骨髓基质细胞即使在有1,25-二羟维生素D3的情况下也不会产生破骨细胞功能。然而,只有在1,25-二羟维生素D3存在时,在与低密度骨髓细胞或造血细胞系共培养骨髓基质细胞的骨切片上,才观察到骨表面有广泛的凹陷。当骨髓基质细胞用戊二醛固定杀死时,也得到了类似的结果;3T3细胞无法替代基质细胞。这些结果有力地证明破骨细胞源自造血干细胞,并表明尽管成熟破骨细胞既没有1,25-二羟维生素D3的受体,也对其无反应,但该激素通过直接作用于造血细胞而非骨髓基质中的某些辅助细胞来诱导破骨细胞功能。能够使该细胞系的其他造血后代分化的3T3细胞未能诱导破骨细胞分化,这表明骨髓基质具有与诱导其他造血细胞分化所需特征不同的额外特征,而这些特征是破骨细胞分化所特有的。